10th February 2023
- 0 comments
Evonetix, the synthetic biology company bringing semiconductor technology to DNA synthesis, has completed a USD $24 million financing round, extending its total series B funding to over USD $54 million (circa GB £44 million). This fundraise was led by existing investor Foresite Capital, with Molten Ventures, Morningside, DCVC, Cambridge Consultants, Civilization Ventures and Providence also participating in the round.
...In order to read the full story we need you to be registered with us, please click the links below to login or register.